Hepion Pharmaceuticals, Inc. - Common Stock, $.0001 par value (HEPA)

CUSIP: 426897302

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 5 signals
Share change
+113
SEC-reported price per share
$0.47
Number of holders
1
Value change
+$53
Number of buys
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
10,619,449

Security key

426897302

Report period

Q2 2025

Institutions

1

Top holders

0

Ownership snapshot

Top reported holders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, $.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BIGGER CAPITAL FUND L P
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
2/15
Latest evidence
31 Mar 2025
13D/G 13F 3/4/5 Lead comparable stake: 10% 13 rows are not safely comparable across share classes. 13D/G row: BIGGER CAPITAL FUND L P Showing 1-6 of 15 holder rows.

Quick read

BIGGER CAPITAL FUND L P leads the comparable SEC ownership view at 10%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BIGGER CAPITAL FUND L P's linked filing trail.
Comparable ownership Top 2
BIGGER CAPITAL FUND L P 10%
Anson Funds Management LP 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BIGGER CAPITAL FUND L P
13D/G
10%
$21,218
1,060,883 shares
$0 21 Jan 2025
Anson Funds Management LP
13F 13D/G
Company
4.9%
from 13D/G
$45,434
105,685 shares
31 Mar 2025
SABBY MANAGEMENT, LLC
13F
Company
13F
class O/S missing
$359,661
836,615 shares
31 Mar 2025
Dr. Robert T. Foster
3/4/5
CEO and Director, Director
class O/S missing
$153,934
50,470 shares
18 Sep 2023
Peter Wijngaard
3/4/5
Director
class O/S missing
$28,978
9,501 shares
24 Nov 2023
HRT FINANCIAL LP
13F
Company
13F
class O/S missing
$7,000
16,387 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Archived quarter

Historical 13F summary for Q2 2025

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, $.0001 par value as of Q2 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .